Pearl #2 Cochrane Analysis: somewhat favors nebs over inhalers in AECOPD, but inhalers deliver a more potent dose, are cheaper, less aerosolizing, and more portable. Start with nebs, then switch to inhalers - an opportunity for inhaler teaching! https:/
RT @ExtraLucht: Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.…
Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.co/GDONMu9mUY
RT @ExtraLucht: #nebuliser has no benefit over #inhalers for #lung #attacks (#exacerbations) of #COPD https://t.co/GDONMu9mUY
RT @ExtraLucht: #nebuliser has no benefit over #inhalers for #lung #attacks (#exacerbations) of #COPD https://t.co/GDONMu9mUY
RT @ExtraLucht: #nebuliser has no benefit over #inhalers for #lung #attacks (#exacerbations) of #COPD https://t.co/GDONMu9mUY
RT @ExtraLucht: #nebuliser has no benefit over #inhalers for #lung #attacks (#exacerbations) of #COPD https://t.co/GDONMu9mUY
#nebuliser has no benefit over #inhalers for #lung #attacks (#exacerbations) of #COPD https://t.co/GDONMu9mUY
#vernevelaar vaak niet nodig bij #COPD en #longaanval. Mooie #besparing en dus beter voor de #patient ! https://t.co/GDONMu9mUY
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @ExtraLucht: #Nebuliser just as good as #inhaler for #lungattack in #copd https://t.co/GDONMtRLwo
RT @ExtraLucht: #Nebuliser just as good as #inhaler for #lungattack in #copd https://t.co/GDONMtRLwo
RT @ExtraLucht: #Nebuliser just as good as #inhaler for #lungattack in #copd https://t.co/GDONMtRLwo
#Nebuliser just as good as #inhaler for #lungattack in #copd https://t.co/GDONMtRLwo
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
@drdjrobs have fun on the Cochrane account! Look forward to your reports. Could you tweet once about this review? https://t.co/GDONMu9mUY
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @Inspire4lifeorg: Hospitals and paramedics Giving out wrong msg when 1st course of action is a neb. Pts think that makes them better htt…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
At odds with patient experience. ...why? https://t.co/keOTjb8uWR
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @Inspire4lifeorg: Absolutely bang on. And we blast copd pts with huge doses B2A and then wonder why they go into HF https://t.co/sJPMuZp…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @Inspire4lifeorg: Hospitals and paramedics Giving out wrong msg when 1st course of action is a neb. Pts think that makes them better htt…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @Inspire4lifeorg: Absolutely bang on. And we blast copd pts with huge doses B2A and then wonder why they go into HF https://t.co/sJPMuZp…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @Inspire4lifeorg: @marshaj1772 @SarahDuganWHCT @SurgeryCornhill very important Cochrane r/v for clinical practice. Also save ££££ https…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
@marshaj1772 @SarahDuganWHCT @SurgeryCornhill very important Cochrane r/v for clinical practice. Also save ££££ https://t.co/HcXKfYOF4H
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for Ex of COPD - Cochrane @UW_AdvPractice https://t.co/l4VnUiTVF8
RT @PCRSUK: There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLK…
Absolutely bang on. And we blast copd pts with huge doses B2A and then wonder why they go into HF https://t.co/sJPMuZpDdr
There is a no evidence in favour of nebulisers versus pMDI plus spacer bronchodilators for COPD exacerbations: https://t.co/rLKuLwJW0E #COPD
RT @ExtraLucht: Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.…
RT @ExtraLucht: Bronchodilators delivered by #nebuliser versus #inhalers for #lungattacks https://t.co/GDONMu9mUY #copd https://t.co/uZS7KN…
RT @ExtraLucht: Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.…
Bronchodilators delivered by #nebuliser versus #inhalers for #lungattacks https://t.co/GDONMu9mUY #copd https://t.co/uZS7KNv4Cd
Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.co/GDONMu9mUY
Broncodilatadores administrados por nebulizador versus inhaladores para los ataques pulmonares en la EPOC Cochrane https://t.co/gunIJGGqM0
RT @CochraneAirways: Just met with one of our authors, Wouter van Geffen, @ExtraLucht at #ERSLDN2016 - he recently published this review ht…
RT @CochraneAirways: Just met with one of our authors, Wouter van Geffen, @ExtraLucht at #ERSLDN2016 - he recently published this review ht…
Just met with one of our authors, Wouter van Geffen, @ExtraLucht at #ERSLDN2016 - he recently published this review https://t.co/tARa98DddH
RT @CochraneAirways: Bronchodilators delivered by nebuliser vs pMDI with spacer or DPI for exacerbations of COPD review now published https…
RT @CochraneAirways: Bronchodilators delivered by nebuliser vs pMDI with spacer or DPI for exacerbations of COPD review now published https…
RT @CochraneAirways: Bronchodilators delivered by nebuliser vs pMDI with spacer or DPI for exacerbations of COPD review now published https…
Bronchodilators delivered by nebuliser vs pMDI with spacer or DPI for exacerbations of COPD review now published https://t.co/tARa98UO5f 1/6
RT @FarmaciaOesteAP: (Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
RT @FarmaciaOesteAP: (Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
RT @FarmaciaOesteAP: (Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
RT @FarmaciaOesteAP: (Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
RT @FarmaciaOesteAP: (Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
(Cochrane) Broncodilatadores en exacerbaciones de EPOC: nebulizador vs. inhalador https://t.co/qS5AvYkwMy
RT @silvervalleydoc: Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic… https://t.co/q48ZcaMfU5
Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic… https://t.co/q48ZcaMfU5
@CochraneLibrary Could you post a tweet about the new review about nebulisers? If possible one Altmetric would use? https://t.co/VxQRae8fKa
RT @pedrojmarcos: Del clásico refrán "De donde no hay no se puede sacar" nebulizaciones va. MDI https://t.co/Ju1VUiuEBK
Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease https://t.co/GDONMu9mUY
New #CochraneEvidence: Nebulisers versus pMDI for exacerbations of COPD - van Geffen - 2016 https://t.co/cXXWsGbxKt @Cochraneairways
Del clásico refrán "De donde no hay no se puede sacar" nebulizaciones va. MDI https://t.co/Ju1VUiuEBK
RT @Aller_MD: Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD https://t.co/eM1bsRIUkM
RT @Aller_MD: Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD https://t.co/eM1bsRIUkM
RT @Aller_MD: Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD https://t.co/eM1bsRIUkM
RT @Aller_MD: Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD https://t.co/eM1bsRIUkM
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD https://t.co/eM1bsRIUkM
Bronchodilators delivered by nebuliser versus pMDI wit.... https://t.co/HKAgaqx3nc
RT @ExtraLucht: Bronchodilators delivered by nebuliser versus pMDI wit.... https://t.co/jllnjDsqs1 @CochraneAirways @CochraneUK #lungattac…
RT @ExtraLucht: Nieuw cochrane bewijs door onderzoek @MCLeeuwarden en @umcg over #vernevelaars en #inhalators tijdens #longaanval. https://…
RT @ExtraLucht: New #cochrane review about #nebulisers in #Copd and #lungattack @CochraneLibrary by @umcg and @MCLeeuwarden https://t.co/lD…
Bronchodilators delivered by nebuliser versus pMDI wit.... https://t.co/jllnjDsqs1 @CochraneAirways @CochraneUK #lungattack #copd #inhalers
Nieuw cochrane bewijs door onderzoek @MCLeeuwarden en @umcg over #vernevelaars en #inhalators tijdens #longaanval. https://t.co/k5RR1dKiNn
New #cochrane review about #nebulisers in #Copd and #lungattack @CochraneLibrary by @umcg and @MCLeeuwarden https://t.co/lDmzTeMWBq